Endocyte, Inc. (ECYT) Social Stream ECYT Home News Ratings Charts Social Warning: This security is no longer trading. Novartis successfully completes acquisition of Endocyte Endocyte, Inc. (ECYT): $23.99 -0.01 (-0.04%) POWR Rating Component Grades Sign Up to See Ratings...FREE! We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now. Just click the link above. Growth S Value I Momentum G Stability N Sentiment U Quality P Add ECYT to Watchlist Sign Up Industry: Biotech Ranked of NR in industry See All 'A' Rated Buy Stocks Loading social stream, please wait... GET POWR RATINGS... FREE! Most Popular Stories View All • Recession is Here...Watch Out Below! • 3 Tech Stocks to Buy as Inflation Expectations Ease • Stocks to Fall MUCH FURTHER this Bear Market Cycle • Buy These Stock Splits as Analysts See Upside • 3 Biotech Stocks to Buy Now View All Top Stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!